Photo: gradyreese/Getty Images
Editor's note: This article has been corrected to reflect Angle Health's current raise of $134 million in Series B funding.
California-based Artera.io, which utilizes humans and AI agents for patient communications, has secured $65 million in growth investment and will have $100 million in Contracted Annual Recurring Revenue (CARR) by the end of the year.
Existing investors participated in the round, including Lead Edge Capital (lead investor), Health Velocity Capital, Heritage Medical Systems and Jackson Square Ventures.
The company will use the funds to scale its business.
"The race to leverage Agentic AI in healthcare will not be won with technology alone; building AI agents is quickly becoming commoditized," Guillaume de Zwirek, CEO and cofounder of Artera.io, said in a statement.
"Success requires technology paired with deep domain experience, extensive real-world data and distribution channels that allow for quick and easy activation."
Angle Health, a health insurance and benefits provider, raised $134 million in an oversubscribed Series B funding round, bringing its total raise to nearly $200 million.
The round was led by Portage and major investors, including Blumberg Capital, Mighty Capital, PruVen Capital, SixThirty Ventures, TSVC, Wing VC and Y Combinator.
The round included a combination of debt and equity, and the company will use the funds to scale its operations.
"The healthcare benefits ecosystem wasn't designed for the small-to-medium-sized businesses that employ nearly half of America's workforce, and legacy technology can't deliver on the efficiencies and savings unlocked by AI," Ty Wang, cofounder and CEO of Angle Health, said in a statement.
"We're rebuilding healthcare infrastructure and care pathways to give all employers access to the comprehensive benefits historically reserved for large enterprises."
Trial Library, which uses AI to recruit and retain participants for clinical trials, has secured $10 million in Series A funding, bringing its total raise to $15 million.
The round was co-led by SemperVirens Venture Capital and Next Ventures, with participation from Sanofi Ventures, Civilization Ventures, How Women Invest, Overwater Ventures, Lux Capital and others.
The company, which launched in 2022, partners with community healthcare providers to help connect patients to clinical trials. Trial says it partners with global biopharmaceutical companies to accelerate research and development and enrollment.
"Trial Library is the first technology company to unlock the payer market to effectively broaden the pool of patients who are considered for clinical trials," Allison Baum Gates, general partner of SemperVirens Venture Capital, said in a statement.
"We're excited to back a platform that aligns incentives and unites patients, providers, payers, and life-science partners around shared cost-savings and patient outcomes."
